Open Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid Arthritis
Clinical trial NCT00160693 · COMPLETED
Trial details
- NCT number
- NCT00160693
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Primary completion
- 2011-02-01
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.